Viridian Therapeutics (VRDN) Free Cash Flow (2013 - 2026)
Viridian Therapeutics (VRDN) free cash flow from Jun 30, 2013 to Mar 31, 2026. The TTM Viridian Therapeutics (VRDN) free cash flow is -$304M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Free Cash Flow
Quarterly Free Cash Flow
Viridian Therapeutics (VRDN) Free Cash Flow CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +8.37% |
| 3 Years TTM | +30.88% |
| 5 Years TTM | +55.95% |
| 10 Years TTM | +43.72% |
| All Time TTM | +68.08% |
Annual Free Cash Flow change of Viridian Therapeutics (VRDN)
| Year | Free Cash Flow | Change |
|---|---|---|
| 2026 | -$120M | -56.78% |
| 2025 | -$277M | +18.92% |
| 2024 | -$233M | +25.81% |
| 2023 | -$185M | +95.55% |
| 2022 | -$95M | +72.32% |
| 2021 | -$55M | +84.17% |
| 2020 | -$30M | -17.49% |
| 2019 | -$36M | +32.43% |
| 2018 | -$27M | -3.98% |
| 2017 | -$28M | +293.08% |
| 2016 | -$7.23M | +2.99% |
| 2015 | -$7.02M | +183.06% |
| 2014 | -$2.48M | +110.17% |
| 2013 | -$1.18M | N/A |
Comparison Viridian Therapeutics (VRDN) five years free cash flow CAGR with competitors
Viridian Therapeutics (VRDN) five years free cash flow CAGR is 55.97%.